Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dougald M Monroe

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
The Journal of Trauma|November 11, 2003
The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patientsZhi Hong Meng, Alisa S Wolberg, Dougald M Monroe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2005
Platelet heterogeneity: variation in coagulation complexes on platelet subpopulationsChristine L Kempton, Maureane Hoffman, Harold R Roberts, et al.
The Journal of Trauma|June 24, 2004
A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet functionAlisa S Wolberg, Zhi Hong Meng, Dougald M Monroe, et al.
Thrombosis Research|February 27, 2016
A novel one-step purification of mouse factor IXVijaya S Pilli, William E Plautz, Dougald M Monroe, et al.
Analytical Biochemistry|May 16, 2019
Assessing the impact of product inhibition in a chromogenic assayMichael T Stobb, Dougald M Monroe, Karin Leiderman, et al.
Thrombosis Research|June 5, 2012
Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitorJen-Yea Chang, Pichika Chantrathammachart, Dougald M Monroe, et al.
Blood|July 12, 2024
Blood coagulation factor IX: structural insights impacting hemophilia B therapyMettine H A Bos, Rianne E van Diest, Dougald M Monroe
Blood|December 31, 2002
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic riskAlisa S Wolberg, Dougald M Monroe, Harold R Roberts, et al.
British Journal of Haematology|June 22, 2006
Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophiliaGeoffrey A Allen, Maureane Hoffman, Harold R Roberts, et al.
Journal of Thrombosis and Thrombolysis|June 23, 2009
A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generationZoya Volovyk, Dougald M Monroe, YiWei Qi, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The Journal of Trauma|November 11, 2003
The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patientsZhi Hong Meng, Alisa S Wolberg, Dougald M Monroe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2005
Platelet heterogeneity: variation in coagulation complexes on platelet subpopulationsChristine L Kempton, Maureane Hoffman, Harold R Roberts, et al.
The Journal of Trauma|June 24, 2004
A systematic evaluation of the effect of temperature on coagulation enzyme activity and platelet functionAlisa S Wolberg, Zhi Hong Meng, Dougald M Monroe, et al.
Thrombosis Research|February 27, 2016
A novel one-step purification of mouse factor IXVijaya S Pilli, William E Plautz, Dougald M Monroe, et al.
Analytical Biochemistry|May 16, 2019
Assessing the impact of product inhibition in a chromogenic assayMichael T Stobb, Dougald M Monroe, Karin Leiderman, et al.
Thrombosis Research|June 5, 2012
Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitorJen-Yea Chang, Pichika Chantrathammachart, Dougald M Monroe, et al.
Blood|July 12, 2024
Blood coagulation factor IX: structural insights impacting hemophilia B therapyMettine H A Bos, Rianne E van Diest, Dougald M Monroe
Blood|December 31, 2002
Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic riskAlisa S Wolberg, Dougald M Monroe, Harold R Roberts, et al.
British Journal of Haematology|June 22, 2006
Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophiliaGeoffrey A Allen, Maureane Hoffman, Harold R Roberts, et al.
Journal of Thrombosis and Thrombolysis|June 23, 2009
A rationally designed heparin, M118, has anticoagulant activity similar to unfractionated heparin and different from Lovenox in a cell-based model of thrombin generationZoya Volovyk, Dougald M Monroe, YiWei Qi, et al.
Pageof 8